l-carnitine structural formula Levocarnitine Carnitine C7h15no3 Molecule Stock Vector (Royalty Free) 1713968104 butenyl]oxy] L-carnitine Levocarnitine Carnitine C7h15no3 Molecule
Description
Nassirpour, R
![l-carnitine structural formula Levocarnitine Carnitine C7h15no3 Molecule Stock Vector (Royalty Free) 1713968104 butenyl]oxy] L-carnitine Levocarnitine Carnitine C7h15no3 Molecule](https://www.shutterstock.com/shutterstock/photos/2344685333/display_1500/stock-vector-l-carnitine-levocarnitine-carnitine-c-h-no-molecule-skeletal-chemical-formula-paper-2344685333.jpg)
TMAO and Acute Coronary Syndrome (ACS) More than half of cardiovascular deaths are caused by ACS, and the main cardiovascular disorder causing these acute cardiovascular events is the development of atherosclerosis ( In summary, TMAO is an independent risk factor for the risk estimation of malignant cardiovascular disease
Both cases were accompanied by obesity and abnormal serum levels of the liver enzymes (Kumra et al
![l-carnitine structural formula Levocarnitine Carnitine C7h15no3 Molecule Stock Vector (Royalty Free) 1713968104 butenyl]oxy] L-carnitine Levocarnitine Carnitine C7h15no3 Molecule](https://i.pinimg.com/736x/e5/e1/72/e5e1723522e8e8b7c026de010e4ff757.jpg)
![l-carnitine structural formula Levocarnitine Carnitine C7h15no3 Molecule Stock Vector (Royalty Free) 1713968104 butenyl]oxy] L-carnitine Levocarnitine Carnitine C7h15no3 Molecule](https://www.thermofisher.com/TFS-Assets/CCG/Chemical-Structures/chemical-structure-cas-6645-46-1.jpg-150.jpg)